tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 167 are a BUY (69.58%), 52 are a HOLD (21.67%), 21 are a SELL (8.75%).
Analyst Andrew Berens, carries an average stock price target met ratio of 54.53% that have a potential upside of 32.31% achieved within 222 days. Previously, Andrew Berens worked at LEERINK.
Andrew Berens’s has documented 464 price targets and ratings displayed on 38 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on COGT, Cogent Biosciences at 09-Dec-2024.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$71
$36.59 (106.34%)
$75
1 months 20 days ago
(02-May-2025)
6/8 (75%)
$40.9 (135.88%)
477
Buy
$57
$22.59 (65.65%)
$55
6 months 12 days ago
(10-Dec-2024)
5/6 (83.33%)
$10.98 (23.86%)
84
Buy
$51
$16.59 (48.21%)
8 months 12 days ago
(10-Oct-2024)
1/1 (100%)
$9.18 (21.95%)
27
Hold
$56
$21.59 (62.74%)
$61
8 months 26 days ago
(27-Sep-2024)
10/13 (76.92%)
$10.39 (22.78%)
223
Hold
$46
$11.59 (33.68%)
$30
1 years 9 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
What Year was the first public recommendation made by Andrew Berens?
